iShares U.S. Pharmaceuticals ETF (IHE) Institutional Ownership $91.51 0.00 (0.00%) As of 05/22/2026 04:10 PM Eastern Add Compare Share Share Ownership Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatingsShort InterestBuy This Stock Institutional Ownership Changes (13F Filings) for iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)Number ofInstitutional Buyers(last 12 months)100TotalInstitutional Inflows(last 12 months)$151.88MNumber ofInstitutional Sellers(last 12 months)45TotalInstitutional Outflows(last 12 months)$51.86M Get IHE Insider Trade Alerts Want to know when executives and insiders are buying or selling iShares U.S. Pharmaceuticals ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data IHE Institutional Buying and Selling by Quarter iShares U.S. Pharmaceuticals ETF Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/21/2026 Raab & Moskowitz Asset Management LLC3,779$328K0.1%-7.2%0.035% 5/19/2026 Western Wealth Management LLC1,729$150K0.0%N/A0.016% 5/19/2026 Bank of America Corp DE456,606$39.58M0.0%+2.8%4.228% 5/18/2026 Sunbelt Securities Inc.960$83K0.0%+14.3%0.009% 5/18/2026 Royal Bank of Canada116,293$10.08M0.0%-25.9%1.077% 5/13/2026 Cetera Investment Advisers109,471$9.49M0.0%+675.4%1.014% 5/8/2026 PNC Financial Services Group Inc.1,365$118K0.0%-43.5%0.013% 5/8/2026 Summit Global Investments6,729$583K0.0%N/A0.062% 5/8/2026 Cassaday & Co Wealth Management LLC977$85K0.0%N/A0.009% 5/5/2026 D.A. Davidson & CO.18,816$1.63M0.0%-6.6%0.174% Get the Latest News and Ratings for IHE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. 5/4/2026 Lifeworks Advisors LLC3,473$301K0.0%N/A0.032% 5/1/2026 Fifth Third Bancorp6,560$569K0.0%+462.1%0.061% 4/30/2026 Kestra Advisory Services LLC6,303$546K0.0%+10.0%0.058% 4/28/2026 Raleigh Capital Management Inc.8,659$751K0.3%+865,800.0%0.079% 4/27/2026 Private Advisor Group LLC3,530$306K0.0%-3.7%0.032% 4/25/2026 Heritage Oak Wealth Advisors LLC6,117$530K0.2%N/A0.056% 4/24/2026 Root Financial Partners LLC696$60K0.0%+36.5%0.006% 4/24/2026 American Institute for Advanced Investment Management LLP5,351$464K0.3%N/A0.049% 4/22/2026 Janney Montgomery Scott LLC6,865$595K0.0%-34.0%0.063% 4/22/2026 Cornerstone Wealth Group LLC2,847$246K0.0%+13.7%0.026% 4/20/2026 Brown Lisle Cummings Inc.2,196$190K0.0%-7.6%0.020% 4/17/2026 AdvisorNet Financial Inc40,993$3.55M0.2%+2.5%0.374% 4/17/2026 Matthew Goff Investment Advisor LLC3,615$313K0.1%N/A0.033% 4/17/2026 FFG Partners LLC3,605$312K0.1%N/A0.033% 4/16/2026 Lee Johnson Capital Management LLC18,493$1.60M0.6%N/A0.169% 3/17/2026 Rockefeller Capital Management L.P.6,415$544K0.0%-39.8%0.057% 3/9/2026 Corient Private Wealth LLC6,506$552K0.0%+3.1%0.058% 2/19/2026 Axxcess Wealth Management LLC9,062$769K0.0%+27.7%0.081% 2/19/2026 Corient Private Wealth LLC6,506$552K0.0%+3.1%0.058% 2/18/2026 Ameriflex Group Inc.291$25K0.0%-50.0%0.003% 2/18/2026 Beacon Pointe Advisors LLC26,621$2.26M0.0%+50.4%0.238% 2/18/2026 NewEdge Advisors LLC963$82K0.0%-20.5%0.009% 2/18/2026 VestGen Advisors LLC23,549$2.00M0.1%N/A0.210% 2/17/2026 EFG International AG447$38K0.0%N/A0.004% 2/17/2026 Cetera Investment Advisers14,118$1.20M0.0%+7.9%0.126% 2/17/2026 Osaic Holdings Inc.42,672$3.62M0.0%+346.3%0.381% 2/17/2026 Royal Bank of Canada156,973$13.32M0.0%+51.9%1.402% 2/16/2026 Mariner LLC25,367$2.15M0.0%-4.0%0.226% 2/13/2026 Kestra Advisory Services LLC5,732$486K0.0%+21.4%0.051% 2/13/2026 Marshall Wace LLP14,338$1.22M0.0%N/A0.128% Nobody Understands Why Trump Is Invading Iran (here’s the answer) (Ad)Most investors are reacting to the Iran strikes without understanding the underlying motive driving the decision. Addison Wiggin, Founder of Grey Swan Investment Fraternity, says there is a hidden reason behind the bombing - and knowing it could change how you position your money right now.Discover the real reason behind the Iran strikes before markets react2/13/2026 Acumen Wealth Advisors LLC1,480$126K0.0%N/A0.013% 2/13/2026 Wells Fargo & Company MN50,907$4.32M0.0%+25.3%0.455% 2/12/2026 Federation des caisses Desjardins du Quebec4,935$419K0.0%+6.4%0.044% 2/12/2026 Commonwealth Equity Services LLC26,515$2.25M0.0%-9.0%0.237% 2/12/2026 Steward Partners Investment Advisory LLC711$60K0.0%+125.7%0.006% 2/12/2026 Bank of Montreal Can22,473$1.91M0.0%+27.0%0.201% 2/12/2026 Hudock Inc.3,034$257K0.0%+3.9%0.027% 2/11/2026 Janney Montgomery Scott LLC10,401$882K0.0%+54.2%0.093% 2/11/2026 Capital Analysts LLC1,400$119K0.0%+118.1%0.013% 2/11/2026 Commonwealth Retirement Investments LLC6,146$521K0.2%N/A0.055% 2/11/2026 LPL Financial LLC137,747$11.69M0.0%+21.3%1.230% 2/11/2026 O Shaughnessy Asset Management LLC463$39K0.0%+35.0%0.004% 2/11/2026 JPMorgan Chase & Co.212,805$18.05M0.0%+89.4%1.900% 2/10/2026 Goldman Sachs Group Inc.82,878$7.03M0.0%-43.1%0.740% 2/10/2026 Spinnaker Trust15,849$1.34M0.1%-12.7%0.142% 2/10/2026 Root Financial Partners LLC510$43K0.0%+88.9%0.005% 2/10/2026 One Capital Management LLC15,252$1.29M0.0%-10.3%0.136% 2/10/2026 Peapack Gladstone Financial Corp31,463$2.67M0.0%-2.4%0.281% 2/10/2026 BNP Paribas Financial Markets103,016$8.74M0.0%+3.0%0.920% 2/10/2026 Blueline Advisors LLC480$41K0.0%N/A0.004% 2/10/2026 Concord Investment Counsel Inc.50,022$4.24M1.4%-3.3%0.447% 2/10/2026 Northwestern Mutual Wealth Management Co.2,553$217K0.0%+28.5%0.023% 2/10/2026 Foundations Investment Advisors LLC642,617$54.51M0.7%N/A5.738% 2/9/2026 Ellerson Group Inc. ADV2,619$222K0.2%N/A0.023% 2/9/2026 Harbour Investments Inc.1,799$153K0.0%+260.5%0.016% 2/9/2026 Fisher Asset Management LLC2,825,644$239.70M0.1%-2.1%25.229% 2/9/2026 Accent Capital Management LLC500$42K0.0%N/A0.004% 2/6/2026 Axxcess Wealth Management LLC9,062$769K0.0%+27.7%0.081% 2/6/2026Global Retirement Partners LLC837$71K0.0%+194.7%0.007% 2/6/2026 Prevail Innovative Wealth Advisors LLC53,387$4.53M0.8%N/A0.477% 2/6/2026 Banque Cantonale Vaudoise24,500$2.08M0.1%N/A0.219% 2/6/2026 PNC Financial Services Group Inc.2,416$205K0.0%-40.7%0.022% 2/6/2026 Csenge Advisory Group3,200$271K0.0%N/A0.029% 2/6/2026 Aviance Capital Partners LLC2,412$205K0.0%N/A0.022% 2/6/2026 HighTower Advisors LLC9,080$770K0.0%-2.1%0.081% 2/5/2026 AlphaCore Capital LLC3,090$262K0.0%N/A0.028% 2/3/2026 Financial Partners Group Inc3,753$325K0.0%N/A0.034% 2/3/2026 Patten & Patten Inc. TN26,755$2.27M0.1%+1.4%0.239% 2/3/2026 GRIMES & Co WEALTH MANAGEMENT LLC22,429$1.90M0.0%+4.3%0.200% 2/3/2026 Anfield Capital Management LLC117,965$10.01M3.2%N/A1.053% 2/2/2026 Truist Financial Corp8,613$731K0.0%-2.8%0.077% 2/2/2026 Advisors Preferred LLC1,655$140K0.0%N/A0.015% 1/29/2026Comerica Bank6,330$537K0.0%+204.0%0.056% 1/29/2026 D.A. Davidson & CO.20,148$1.71M0.0%N/A0.179% 1/29/2026 UBS Group AG38,810$3.29M0.0%+15.0%0.345% 1/29/2026 Concurrent Investment Advisors LLC2,862$243K0.0%N/A0.025% 1/29/2026 NBC Securities Inc.630$53K0.0%+46.5%0.006% 1/28/2026 Arkansas Financial Group Inc.7,135$605K0.1%-3.8%0.063% 1/28/2026 Kingswood Wealth Advisors LLC3,900$331K0.0%+25.8%0.035% 1/27/2026 TD Waterhouse Canada Inc.870$74K0.0%+34.9%0.008% Your book is inside (Ad)The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.Download your copy now.1/27/2026 Institute for Wealth Management LLC.11,273$956K0.1%+6.7%0.100% 1/26/2026 Cornerstone Wealth Group LLC2,505$213K0.0%N/A0.022% 1/26/2026 CWM LLC776$66K0.0%+128.9%0.007% 1/26/2026 Childress Capital Advisors LLC12,000$1.02M0.2%N/A0.107% 1/26/2026 Massachusetts Wealth Management15,230$1.29M0.6%-1.6%0.135% 1/23/2026 Farther Finance Advisors LLC1,312$111K0.0%N/A0.012% 1/23/2026 Assetmark Inc.465$39K0.0%+203.9%0.004% 1/23/2026 U.S. Capital Wealth Advisors LLC7,608$645K0.0%+2.8%0.067% 1/20/2026 Stratos Wealth Advisors LLC6,546$555K0.0%N/A0.058% 1/14/2026 Beacon Investment Advisory Services Inc.3,060$260K0.0%N/A0.027% IHE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of IHE shares? During the previous two years, 169 institutional investors and hedge funds held shares of iShares U.S. Pharmaceuticals ETF. The most heavily invested institutionals were Fisher Asset Management LLC ($239.70M), Foundations Investment Advisors LLC ($54.51M), Bank of America Corp DE ($39.58M), McElhenny Sheffield Capital Management LLC ($18.94M), JPMorgan Chase & Co. ($18.05M), Aptus Capital Advisors LLC ($12.17M), and Rockport Wealth LLC ($12.09M).Learn more on iShares U.S. Pharmaceuticals ETF's institutional investors. Which institutional investors have been buying iShares U.S. Pharmaceuticals ETF's stock? Of the 151 institutional investors that purchased iShares U.S. Pharmaceuticals ETF's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Foundations Investment Advisors LLC ($642.62K), JPMorgan Chase & Co. ($381.95K), McElhenny Sheffield Capital Management LLC ($285.61K), BNP Paribas Financial Markets ($203.02K), Aptus Capital Advisors LLC ($183.44K), Rockport Wealth LLC ($182.32K), and Raymond James Financial Inc. ($138.06K). How much institutional buying is happening at iShares U.S. Pharmaceuticals ETF? Institutional investors have bought a total of 1,877,069 shares in the last 24 months. This purchase volume represents approximately $151.88M in transactions. Which of iShares U.S. Pharmaceuticals ETF's major shareholders have been selling company stock? Of the 45 institutional investors that sold iShares U.S. Pharmaceuticals ETF's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Fisher Asset Management LLC ($317.31K), BNP Paribas Financial Markets ($100K), Goldman Sachs Group Inc. ($62.89K), Royal Bank of Canada ($40.68K), Citadel Advisors LLC ($31.49K), Susquehanna International Group LLP ($27.73K), and Bank of America Corp DE ($26.12K). How much institutional selling is happening at iShares U.S. Pharmaceuticals ETF? Institutional investors have sold a total of 701,314 shares in the last 24 months. This volume of shares sold represents approximately $51.86M in transactions. Related Companies FXH Institutional Ownership PPH Institutional Ownership IHF Institutional Ownership RSPH Institutional Ownership LABU Institutional Ownership BBH Institutional Ownership XPH Institutional Ownership PJP Institutional Ownership PINK Institutional Ownership PBE Institutional Ownership This page (NYSEARCA:IHE) was last updated on 5/25/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
